Hsiang-Ting Hsu

Title: Hsiang-Ting Hsu: Innovator in H1N1 Virus Neutralization

Introduction

Hsiang-Ting Hsu is a prominent inventor based in Taipei, Taiwan. He has made significant contributions to the field of biotechnology, particularly in the development of antibodies for viral infections. His work is crucial in the ongoing fight against influenza viruses, specifically the H1N1 strain.

Latest Patents

Hsu holds a patent for H1N1 flu virus neutralizing antibodies. This patent describes an antibody, or a binding fragment of the antibody, against the H1N1 virus. The antibody includes a heavy chain variable region and a light chain variable region. The heavy chain variable region contains complementarity determining regions (CDR) with specific amino acid sequences, while the light chain variable region also contains CDRs with distinct sequences. The patent outlines a method for treating or preventing H1N1 infection in a subject by administering the antibody or its binding fragment.

Career Highlights

Hsiang-Ting Hsu is associated with Medigen Biotechnology Corporation, where he applies his expertise in antibody development. His innovative work has positioned him as a key figure in the biotechnology sector, contributing to advancements in therapeutic solutions for viral infections.

Collaborations

Hsu collaborates with notable colleagues, including Young-Sun Lin and Kuei-Tai Lai. Their combined efforts enhance the research and development capabilities within their organization.

Conclusion

Hsiang-Ting Hsu's contributions to the field of biotechnology, particularly through his patent on H1N1 neutralizing antibodies, highlight his role as an innovator. His work not only advances scientific knowledge but also has the potential to impact public health positively.